CN104337984A - External Chinese medicinal ointment for treating myositis ossificans of elbow joints - Google Patents
External Chinese medicinal ointment for treating myositis ossificans of elbow joints Download PDFInfo
- Publication number
- CN104337984A CN104337984A CN201410635478.1A CN201410635478A CN104337984A CN 104337984 A CN104337984 A CN 104337984A CN 201410635478 A CN201410635478 A CN 201410635478A CN 104337984 A CN104337984 A CN 104337984A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicinal
- medicinal ointment
- chinese medicine
- myositis ossificans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000002310 elbow joint Anatomy 0.000 title claims abstract description 27
- 208000010358 Myositis Ossificans Diseases 0.000 title claims abstract description 15
- 239000002674 ointment Substances 0.000 title claims abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 20
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 210000000582 semen Anatomy 0.000 claims description 10
- 229940025250 camphora Drugs 0.000 claims description 7
- 239000010238 camphora Substances 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 5
- 240000007163 Livistona chinensis Species 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 3
- 208000026435 phlegm Diseases 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 244000306301 Caesalpinia sappan Species 0.000 abstract 1
- 235000015162 Caesalpinia sappan Nutrition 0.000 abstract 1
- 241001233914 Chelidonium majus Species 0.000 abstract 1
- 241000723346 Cinnamomum camphora Species 0.000 abstract 1
- 240000008243 Corypha umbraculifera Species 0.000 abstract 1
- 240000005717 Dioscorea alata Species 0.000 abstract 1
- 235000009815 Momordica Nutrition 0.000 abstract 1
- 241000218984 Momordica Species 0.000 abstract 1
- 229920000473 Phlobaphene Polymers 0.000 abstract 1
- 240000000528 Ricinus communis Species 0.000 abstract 1
- 235000004443 Ricinus communis Nutrition 0.000 abstract 1
- 244000297179 Syringa vulgaris Species 0.000 abstract 1
- 235000004338 Syringa vulgaris Nutrition 0.000 abstract 1
- 241000746716 Typhonium Species 0.000 abstract 1
- 229960000846 camphor Drugs 0.000 abstract 1
- 229930008380 camphor Natural products 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 230000037384 skin absorption Effects 0.000 abstract 1
- 231100000274 skin absorption Toxicity 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 5
- 206010023232 Joint swelling Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 238000002651 drug therapy Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- LSPHULWDVZXLIL-UHFFFAOYSA-N (+/-)-Camphoric acid Chemical class CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010060820 Joint injury Diseases 0.000 description 2
- 208000006735 Periostitis Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 210000003460 periosteum Anatomy 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 239000002893 slag Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000135309 Processus Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Insects & Arthropods (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicine and particularly relates to an external Chinese medicinal ointment for treating myositis ossificans of elbow joints. The external Chinese medicinal ointment is prepared from the following Chinese medicine raw materials in part by weight: 30 parts of cochinchina momordica seed, 20 parts of sappan wood, 10 parts of castor bean, 10 parts of slenderstyle acanthopanax bark, 10 parts of lilac daphne flower, 10 parts of nidus vespae, 10 parts of giant typhonium rhizome, 10 parts of airpotato yam rhizome, 10 parts of blackend swallowwort root, 10 parts of fan palm, 1 part of phlobatannin and 10 parts of camphor. The external Chinese medicinal ointment has effects of removing blood stasis and dispersing phlegm, and promoting blood circulation to remove meridian obstruction, and has the characteristics of local application, skin absorption, straight arrival to lesion, quick response, high treatment effect, no toxic and side effect, safety, convenience and the like.
Description
Technical field
The invention belongs to field of traditional Chinese medicine technology, be specifically related to a kind of external application Chinese medicine unguentum for the treatment of elbow joint myositis ossificans.
Background technology
Elbow joint myositis ossificans is modern medicine name, refers to due to dystopy serious after ancon wound, causes connective tissue to ossify, and is also one of complication the most serious in elbow injuries; After elbow injuries local muscle or periosteum damaged, outer periosteum and surrounding soft tissue is hemorrhage, hematoma causes aseptic inflammation to react; Clinical signs is: elbow joint swelling, pain is prolonged does not heal, and local temperature raises, and exercising elbow joint scope diminishes gradually, tenderness, movable after the pain increased; Be principle for the treatment of clinically by dialectical blood stasis-eliminating and stagnation-dissipating, the promoting blood circulation to remove obstruction in the collateral taked, receive satisfied therapeutic effect.
Summary of the invention
The object of this invention is to provide a kind of external application Chinese medicine unguentum for the treatment of elbow joint myositis ossificans, have instant effect, curative effect high, have no side effect, the feature of safe ready.
The external application Chinese medicine unguentum for the treatment of elbow joint myositis ossificans of the present invention, is made up of the raw material of Chinese medicine of following parts by weight: Semen Momordicae 30 parts, Lignum Sappan 20 parts, Semen Ricini 10 parts, Cortex Acanthopancis 10 parts, Flos Genkwa 10 parts, Nidus Vespae 10 parts, Rhizoma Typhonii 10 parts, Rhizoma Dioscoreae Bulbiferae 10 parts, Radix Cynanchi Atrati 10 parts, seed of Livistona chinensis R.Br. 10 parts, Resina garciniae 1 part, Camphora 10 parts.
Preparation method: qualified for the medicine-feeding process of preparing Chinese medicine, weighing are assorted, except Camphora is placed in frying container, add 200 parts of Oleum Sesami, medicine is fried 2 hours by slow fire; Filter, remove slag; Filtrate decocts 1 hour with high heat, and from fire, 60 parts of Plumbum preparatiums are slowly poured into, stirred evenly, camphorates, stir evenly into cream when oil temperature is down to 40 DEG C, cold water soaks the seven days gas that reduces internal heat.
Usage and dosage: external, little for plaster cremate is opened by the used time, and cream about 20 grams of getting it filled, is coated in the soak cream non-woven fabrics of 10 × 10cm size, sticks affected part, within 3 days, change dressings once, within 51 days, is a course for the treatment of.
Drug action mechanism in the present invention is as follows:
Semen Momordicae: blood stasis-eliminating and stagnation-dissipating, reducing swelling and alleviating pain.
Lignum Sappan: invigorate blood circulation cure the wound, blood stasis dispelling stimulates the menstrual flow.
Semen Ricini: evacuation of pus of drawing out pus by applying a plaster to the affected part, dispelling wind and removing obstruction in the collateral.
Cortex Acanthopancis: wind-damp dispelling, bone and muscle strengthening, diuresis.
Flos Genkwa: removing fluid-retention by purgation, expelling phlegm for arresting cough, dispersing swelling and dissipating binds.
Nidus Vespae: detoxicating and killing parasites, wind-expelling pain-stopping.
Rhizoma Typhonii: the expectorant that dispels the wind, dampness expectorant, relieving convulsion, pain relieving, detoxicating and resolving stagnation of pathogens.
Rhizoma Dioscoreae Bulbiferae: dissipating phlegm and resolving masses, cough-relieving hemostasis.
Radix Cynanchi Atrati: clearing away heat and cooling blood.
Seed of Livistona chinensis R.Br.: hard masses softening and resolving.
Resina garciniae: the removing toxic substances of detumescence and apocenosis, dissipating blood stasis, killing parasites for relieving itching.
Camphora: externally used detumescence eliminating stagnation.
To disappear with Semen Momordicae dissipating blood stasis according to compatibility the present invention and become principal agent, Lignum Sappan invigorate blood circulation cure the wound, eliminating blood stasis and smoothing collaterals is adjuvant, Semen Ricini, Cortex Acanthopancis, Flos Genkwa, Nidus Vespae, Rhizoma Typhonii, Rhizoma Dioscoreae Bulbiferae, Radix Cynanchi Atrati, seed of Livistona chinensis R.Br., Resina garciniae, Camphora are adjuvant altogether.
Above all medicines cure mainly and effect is all referred to college of traditional Chinese medicine's undergraduate course teaching material " Chinese materia medica ", Science and Technology of Shanghai publishing house.
Below for clinical trial is summed up:
The symptom of elbow joint myositis ossificans: elbow joint swelling after wound, pain is prolonged not to heal, scorching hot, the exercising elbow joint obstacle in local, tenderness, movable after the pain increased.
Treatment standard:
Recovery from illness: clinical symptoms all disappears, exercising elbow joint is normal, and without any discomfort, x-ray checks that elbow joint is without exception.
Take a turn for the better: cardinal symptom obviously alleviates, and exercising elbow joint is progress obviously, around x-ray inspection elbow joint, nebulous ossified agglomerate obviously disappears.
Invalid: clinical symptoms is not improved.
Therapeutic outcome: clinical trial treatment elbow joint myositis ossificans Patients with 300 Cases.After a course of therapy fully recover 258 example, account for 86%, take a turn for the better 21 example, account for 7%, invalid 21 example, account for 7%, total effective rate 93%.Shown in treating, without any side effects to patient, three large routine tests and hepatic and renal function detect no abnormal phenomenon.
Below enumerate several model case:
Case 1: patient Cao, man, 50 years old, accidentally got injured by a fall right side elbow joint before 20 days, the right elbow joint swelling of processus aboralis sense in 10 days, tenderness, local is scorching hot, after movable, pain increases the weight of, therefore in my institute of in August, 2012, be diagnosed as right side elbow joint myositis ossificans on inspection, fully recover after giving a course for the treatment of of Drug therapy of the present invention.
Case 2: patient high so-and-so, man, 44 years old, over one month on the right side of patient elbow joint swell and ache, limitation of activity, scorching hot, the tenderness in local, tired postemphasis, oral blood-activating pain stopping tablet of being in is failed to respond to any medical treatment, exacerbation of symptoms.In JIUYUE, 2012 comes my institute, is diagnosed as right side elbow joint myositis ossificans on inspection, fully recovers after giving a course for the treatment of of Drug therapy of the present invention.
Case 3: patient river so-and-so, female, 51 years old, left side elbow joint swelling pain, range of activity were limited, are once diagnosed as elbow joint myositis ossificans at local hospital, multi-treatment two wheat harvesting period fail cure.In August, 2012, my institute, was diagnosed as elbow joint myositis ossificans through further consultation, fully recovered after giving a course for the treatment of of Drug therapy of the present invention.
The present invention compared with prior art, has following beneficial effect:
1. the Chinese medicine that the present invention selects all meets Pharmacopoeia of the People's Republic of China regulation, has effect of blood stasis-eliminating and stagnation-dissipating, promoting blood circulation to remove obstruction in the collateral according to compatibility the present invention.
2. the present invention not only can treat elbow joint myositis ossificans effectively, and also has good therapeutical effect to acute lumbar muscle sprain, scapulohumeral periarthritis.
3. local application of the present invention, through sick institute, instant effect, curative effect be high, have no side effect, safe ready.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described further.
Embodiment 1
The weight of raw material of Chinese medicine consists of: Semen Momordicae 30 parts, Lignum Sappan 20 parts, Semen Ricini 10 parts, Cortex Acanthopancis 10 parts, Flos Genkwa 10 parts, Nidus Vespae 10 parts, Rhizoma Typhonii 10 parts, Rhizoma Dioscoreae Bulbiferae 10 parts, Radix Cynanchi Atrati 10 parts, seed of Livistona chinensis R.Br. 10 parts, Resina garciniae 1 part, Camphora 10 parts.
Preparation method: qualified for the medicine-feeding process of preparing Chinese medicine, weighing are assorted, except Camphora is placed in frying container, add 200 parts of Oleum Sesami, medicine is fried 2 hours by slow fire; Filter, remove slag; Filtrate decocts 1 hour with high heat, and from fire, 60 parts of Plumbum preparatiums are slowly poured into, stirred evenly, camphorates, stir evenly into cream when oil temperature is down to 40 DEG C, cold water soaks the seven days gas that reduces internal heat.
Claims (1)
1. treat an external application Chinese medicine unguentum for elbow joint myositis ossificans, it is characterized in that being made up of the raw material of Chinese medicine of following parts by weight: Semen Momordicae 30 parts, Lignum Sappan 20 parts, Semen Ricini 10 parts, Cortex Acanthopancis 10 parts, Flos Genkwa 10 parts, Nidus Vespae 10 parts, Rhizoma Typhonii 10 parts, Rhizoma Dioscoreae Bulbiferae 10 parts, Radix Cynanchi Atrati 10 parts, seed of Livistona chinensis R.Br. 10 parts, Resina garciniae 1 part, Camphora 10 parts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410635478.1A CN104337984A (en) | 2014-11-13 | 2014-11-13 | External Chinese medicinal ointment for treating myositis ossificans of elbow joints |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410635478.1A CN104337984A (en) | 2014-11-13 | 2014-11-13 | External Chinese medicinal ointment for treating myositis ossificans of elbow joints |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104337984A true CN104337984A (en) | 2015-02-11 |
Family
ID=52494975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410635478.1A Withdrawn CN104337984A (en) | 2014-11-13 | 2014-11-13 | External Chinese medicinal ointment for treating myositis ossificans of elbow joints |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104337984A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104906546A (en) * | 2015-06-18 | 2015-09-16 | 张晓风 | Traditional Chinese medicine preparation for treating traumatic myositis ossificans and preparation method thereof |
CN104998102A (en) * | 2015-06-29 | 2015-10-28 | 苗光丽 | Externally applied drug for preventing myositis ossificans after elbow fracture |
CN105031320A (en) * | 2015-06-29 | 2015-11-11 | 李克军 | Method for preparing externally applied medicament for myositis ossificans |
CN105031322A (en) * | 2015-06-29 | 2015-11-11 | 李青 | Preparation method for intervention medicine after elbow injury |
-
2014
- 2014-11-13 CN CN201410635478.1A patent/CN104337984A/en not_active Withdrawn
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104906546A (en) * | 2015-06-18 | 2015-09-16 | 张晓风 | Traditional Chinese medicine preparation for treating traumatic myositis ossificans and preparation method thereof |
CN104998102A (en) * | 2015-06-29 | 2015-10-28 | 苗光丽 | Externally applied drug for preventing myositis ossificans after elbow fracture |
CN105031320A (en) * | 2015-06-29 | 2015-11-11 | 李克军 | Method for preparing externally applied medicament for myositis ossificans |
CN105031322A (en) * | 2015-06-29 | 2015-11-11 | 李青 | Preparation method for intervention medicine after elbow injury |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103977218B (en) | A kind of Chinese medicinal ointment treating clavus | |
CN104352811A (en) | Plaster for curing bone injury and preparation method thereof | |
CN102309723B (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method of ointment thereof | |
CN104337984A (en) | External Chinese medicinal ointment for treating myositis ossificans of elbow joints | |
CN1939489A (en) | Ointment for treating arthralgia-syndrome and analgesia | |
CN103933129B (en) | Plaster for treating pain | |
CN103463580B (en) | Chinese medicine ointment for treating pain of muscles, bones and joints and preparation method thereof | |
CN103446240B (en) | Traditional Chinese medicine composition for rapidly healing wounds | |
CN104083568A (en) | Miao medicine plaster for ostealgia and preparation method thereof | |
CN103690583A (en) | Medicinal liquor, and preparation method and application thereof | |
CN105748841A (en) | Medicine for treating burns and scalds and preventing healed scar formation and preparation method thereof | |
CN104840839A (en) | Traditional Chinese medicine external lotion for treating tenosynovitis and preparation method | |
CN104997890A (en) | Traditional Chinese medicine preparation for treating fracture | |
CN104523879A (en) | Medicinal wine with effect of treating bone fracture and preparation method | |
CN103655756B (en) | The Chinese medicine for outer use for the treatment of cutization pyogenic infection | |
CN104257908A (en) | Traditional Chinese medicine preparation for treating rheumatic arthritis and preparation method, | |
CN104083421A (en) | Traditional Chinese medicine ointment for treating bedsore and preparation method thereof | |
CN103861071A (en) | Externally applied traditional Chinese medicament for treating scapulohumeral periarthritis | |
CN101357153B (en) | No-scar medicine for treating burn and scald and preparation method thereof | |
CN102343081A (en) | Moxibustion tool of pure Chinese medicinal preparation for treating bone aching and pure Chinese medicinal preparation for treating bone aching | |
CN106729521A (en) | It is a kind of to treat Chinese medicine preparation of apoplexy and preparation method thereof | |
CN105726992A (en) | A plaster for treating bone injuries and a preparing method thereof | |
CN104815090A (en) | External preparation for treating closed injury and preparation method thereof | |
CN104324141A (en) | Traditional Chinese medicine paste for treating scapulohumeral periarthritis | |
CN107050144A (en) | A kind of Chinese medicine for treating traumatic injury |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20150211 |
|
WW01 | Invention patent application withdrawn after publication |